P-272The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)

ABSTRACT:

SUBMITTER: Pascal H 

PROVIDER: S-EPMC4984058 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature